Table 1.

Demographic and clinical characteristics for typically developing children (TDC), children diagnosed with multiple sclerosis (MS) or myelin oligodendrocyte glycoprotein-associated disorders (MOGAD)

	TDC (n = 28)	MS (n = 18)	MOGAD (n = 14)	P-value
Sex (n)
Female	17 (60.7%)	12 (67%)	11 (79%)	0.51
Age at assessment (years)
Mean ± Standard deviation	14.96 ± 2.58 years	16.61 ± 1.09 years	12.14 ± 3.10 years	<0.001
Range	9.00–19.10 years	14.10–18.00 years	7.50–17.30 years
Age at diagnosis (years)
Mean ± Standard deviation	-	14.37 ± 1.61 years	9.44 ± 3.44 years	<0.001
Range	-	14.23–17.40 years	2.90–13.80 years
Time from diagnosis to assessment (years)
Mean ± Standard deviation	-	2.45 ± 1.64 years	3.04 ± 3.20 years	0.79
Range	-	0.16–6.16 years	0.59–11.71 years
Number of clinical events
Mean ± Standard deviation	-	2.06 ± 1.47	2.79 ± 2.33	0.07
Range	-	1–5	1–9
Number of optic neuritis episodes
Mean ± Standard deviation	-	0.61 ± 0.85	1.29 ± 0.91	0.12
Range	-	0–2	0–3
Expanded disability status scale
Mean ± Standard Deviation	-	1.53 ± 0.87	1.21 ± 0.64	0.26
Range	-	0–4.5	0–1.5